Bupivacaine Hydrochloride
- Product NDC
- 55150-250
- 11-digit product format
- 551500250
- Labeler code
- 55150
- Product ID
- 55150-250_39649703-e633-4a20-ba71-0c04dbf8ff2a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupivacaine Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- PERINEURAL
- Labeler
- Eugia US LLC
- Application
- ANDA207183
- Marketing category
- ANDA
- Marketing start
- 2016-05-13
- Substance
- BUPIVACAINE HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207183-001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | |
| A207183-002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207183-001 | AP |
| A207183-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207183-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2016-05-13 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207183-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2016-05-13 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207183-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207183-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207183-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207183-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207183-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207183-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207183-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207183-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207183-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207183-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207183-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207183-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207183-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207183-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207183-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207183-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207183-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207183-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207183-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207183-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207183-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207183-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207183-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207183-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207183-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207183-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207183-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207183-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207183-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A207183-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207183-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207183-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207183-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A207183-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207183-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A207183-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207183-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207183-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207183-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A207183-002 | AP | 1 | bb7c543d1eb4… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bupivacaine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUPIVACAINE HYDROCHLORIDE | 5 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7TQO7W3VT8 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1012396 | Internal RxNorm lookup |
| 1012404 | Internal RxNorm lookup |
| 1724786 | Internal RxNorm lookup |
| 1724787 | Internal RxNorm lookup |
| 1724880 | Internal RxNorm lookup |
| 1724884 | Internal RxNorm lookup |
| 1725078 | Internal RxNorm lookup |
| 1725082 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ffecf450-1f01-4721-8e10-251385852612 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55150-250-50 | Bupivacaine Hydrochloride | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 9 | |
| 55150-250-50 | Bupivacaine Hydrochloride | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55150-250-50 | ML - Milliliter | 55150-250 | d8117f97-6d25-4106-a667-064c9ec26584 | 1 | 2017-10-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7TQO7W3VT8 | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 3 | |
| BUPIVACAINE | ACTIVE MOIETY | Y8335394RO | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 3 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION [AUROMEDICS PHARMA LLC] | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Eugia US LLC | ffecf450-1f01-4721-8e10-251385852612 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 207183 ANDA207183 55150-250 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | A-S Medication Solutions | 1091d4d8-5dad-46e1-8f26-7bc0c5dd833f | 2024-05-31 | Boxed warning, Warnings, Adverse reactions | 207183 ANDA207183 |
| BUPIVACAINE HCI | BUPIVACAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | e37e1599-db88-2fcd-e053-2995a90a00e5 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 207183 ANDA207183 |
| BUPIVACAINE HYDROCHLORIDE injection, solution | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION | HF Acquisition Co LLC, DBA HealthFirst | 06c15208-c600-7173-e063-6394a90a2f94 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | 207183 ANDA207183 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 694926ac-aff0-aa1f-e053-2991aa0a9588 | 2023-05-22 | Boxed warning, Warnings, Adverse reactions | 207183 ANDA207183 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d1642239-4230-b679-e053-2a95a90a3b7c | 2023-05-02 | Boxed warning, Warnings, Adverse reactions | 207183 ANDA207183 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1725078 | BUPivacaine HCl 0.25 % in 10 ML Injection | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1725082 | BUPivacaine HCl 0.25 % in 30 ML Injection | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012396 | BUPivacaine HCl 0.25 % Injectable Solution | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724880 | BUPivacaine HCl 0.5 % in 10 ML Injection | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724884 | BUPivacaine HCl 0.5 % in 30 ML Injection | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012404 | BUPivacaine HCl 0.5 % Injectable Solution | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724787 | BUPivacaine HCl 0.75 % in 10 ML Injection | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724786 | BUPivacaine HCl 0.75 % in 30 ML Injection | PSN | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1725078 | 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724880 | 10 ML bupivacaine hydrochloride 5 MG/ML Injection | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724787 | 10 ML bupivacaine hydrochloride 7.5 MG/ML Injection | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1725082 | 30 ML bupivacaine hydrochloride 2.5 MG/ML Injection | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724884 | 30 ML bupivacaine hydrochloride 5 MG/ML Injection | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724786 | 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012396 | bupivacaine hydrochloride 2.5 MG/ML Injectable Solution | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012404 | bupivacaine hydrochloride 5 MG/ML Injectable Solution | SCD | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1725078 | bupivacaine HCl 0.25 % in 10 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1725082 | bupivacaine HCl 0.25 % per 30 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724880 | bupivacaine HCl 0.5 % in 10 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724884 | bupivacaine HCl 0.5 % in 30 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724787 | bupivacaine HCl 0.75 % in 10 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724786 | bupivacaine HCl 0.75 % in 30 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724786 | bupivacaine HCl 225 MG per 30 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1724787 | bupivacaine HCl 75 MG per 10 ML Injection | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012396 | bupivacaine hydrochloride 0.25 % Injectable Solution | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012404 | bupivacaine hydrochloride 0.5 % Injectable Solution | SY | ffecf450-1f01-4721-8e10-251385852612 | 9 |
| 1012404 | BUPivacaine HCl 0.5 % Injectable Solution | PSN | 1091d4d8-5dad-46e1-8f26-7bc0c5dd833f | 8 |
| 1012404 | bupivacaine hydrochloride 5 MG/ML Injectable Solution | SCD | 1091d4d8-5dad-46e1-8f26-7bc0c5dd833f | 8 |
| 1012404 | bupivacaine hydrochloride 0.5 % Injectable Solution | SY | 1091d4d8-5dad-46e1-8f26-7bc0c5dd833f | 8 |
| 1012404 | BUPivacaine HCl 0.5 % Injectable Solution | PSN | d19bf48e-b64e-4fe4-82ab-12cb444e92c4 | 3 |
| 1116927 | dexAMETHasone sodium phosphate 4 MG/ML (dexAMETHasone phosphate equivalent) Injectable Solution | PSN | d19bf48e-b64e-4fe4-82ab-12cb444e92c4 | 3 |
| 1012404 | bupivacaine hydrochloride 5 MG/ML Injectable Solution | SCD | d19bf48e-b64e-4fe4-82ab-12cb444e92c4 | 3 |
| 1116927 | dexamethasone phosphate 4 MG/ML Injectable Solution | SCD | d19bf48e-b64e-4fe4-82ab-12cb444e92c4 | 3 |
| 1012404 | bupivacaine hydrochloride 0.5 % Injectable Solution | SY | d19bf48e-b64e-4fe4-82ab-12cb444e92c4 | 3 |
| 1116927 | dexamethasone phosphate 4 MG/ML (as dexamethasone sodium phosphate 4.4 MG/ML) Injectable Solution | SY | d19bf48e-b64e-4fe4-82ab-12cb444e92c4 | 3 |
| 1012404 | BUPivacaine HCl 0.5 % Injectable Solution | PSN | d1642239-4230-b679-e053-2a95a90a3b7c | 2 |
| 1012404 | BUPivacaine HCl 0.5 % Injectable Solution | PSN | 06c15208-c600-7173-e063-6394a90a2f94 | 2 |
| 1012404 | bupivacaine hydrochloride 5 MG/ML Injectable Solution | SCD | d1642239-4230-b679-e053-2a95a90a3b7c | 2 |
| 1012404 | bupivacaine hydrochloride 5 MG/ML Injectable Solution | SCD | 06c15208-c600-7173-e063-6394a90a2f94 | 2 |
| 1012404 | bupivacaine hydrochloride 0.5 % Injectable Solution | SY | 06c15208-c600-7173-e063-6394a90a2f94 | 2 |
| 1012404 | bupivacaine hydrochloride 0.5 % Injectable Solution | SY | d1642239-4230-b679-e053-2a95a90a3b7c | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55150-250-50 | 55150025050 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-250-50) / 50 mL in 1 VIAL, MULTI-DOSE | 2016-05-13 | 0000-00-00 | No | No | Current |